News

Filter

Current filters:

Meropenem

1 to 9 of 66 results

Cubist's sales jump 47% on Cubicin sales

09-02-2009

The USA's Cubist Pharmaceuticals has reported a 47% jump in revenue for the full year 2008, year-on-year,…

AstraZenecaCubicinDaptomycin InjectionMeropenemMerrem I.V.

Japan stock market week to Dec 8, 2008

15-12-2008

Tokyo staged a modest pullback in the week ended December 8. The Nikkei 225 edged 0.8% lower, but maintained…

Daiichi SankyoKyowa HakkoMerck KGaAMeropenemMerrem I.V.RocheSankyoShionogi

DSP 1st-half profit hit by NHI price revisions

24-11-2008

Dainippon Sumitomo Pharmaceutical's net income dropped 21% to 10.87 billion yen ($109.8 million) for…

MeropenemMerrem I.V.

Carbapenems see increased use for hospital in-patients in Europe

17-11-2008

Over the January-June 2008 time period, the carbapenem drug class in hospital in-patient courses in Europe…

AstraZenecaErtapenem InjectionInvanzMerck KGaAMeropenemMerrem I.V.

Cubist income up as Cubicin sales rise 45%

27-10-2008

The USA's Cubist Pharmaceuticals increased its income by 40% during the quarter ended September 30, 2008,…

AstraZenecaCubicinDaptomycin InjectionMeropenemMerrem I.V.

Cubist to promote AstraZeneca's Merrem in USA

07-07-2008

USA-based Cubist Pharmaceuticals has signed an exclusive agreement with Anglo-Swedish drug major AstraZeneca…

Amino AcidsAstraZenecaCubicinDaptomycin InjectionInjectionMeropenemMerrem I.V.Physostigmine Salicylate

"Gold rush" on high-value niche antibiotics will take a toll; Datamonitor

10-09-2007

Just weeks following the publication of a new report by independent market analyst Datamonitor highlighting…

CubicinDaptomycin InjectionLinezolidMeropenemMerrem I.V.TigecyclineTygacilZyvox

1 to 9 of 66 results

COMPANY SPOTLIGHT

Menarini

Back to top